Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004562275 | SCV000166022 | benign | Familial adenomatous polyposis 1 | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000163523 | SCV000214081 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000122765 | SCV000524797 | likely benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163523 | SCV000681538 | benign | Hereditary cancer-predisposing syndrome | 2016-05-28 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000122765 | SCV001133312 | benign | not provided | 2019-02-14 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163523 | SCV002538449 | benign | Hereditary cancer-predisposing syndrome | 2021-04-13 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV004562275 | SCV004015892 | benign | Familial adenomatous polyposis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003493448 | SCV004243224 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997373 | SCV004841713 | benign | Classic or attenuated familial adenomatous polyposis | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV003493448 | SCV004848571 | likely benign | not specified | 2021-09-03 | criteria provided, single submitter | clinical testing | The p.Leu87Leu variant in APC is classified as likely benign because it does not alter an amino acid residue, is not located within the splice consensus site, and computational splice prediction tools do not predict an impact on splicing. It has been identified in 0.21% (64/30616) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BP4, BP7. |
Myriad Genetics, |
RCV004562275 | SCV004932628 | benign | Familial adenomatous polyposis 1 | 2024-02-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003493448 | SCV005726227 | benign | not specified | 2024-11-16 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005359148 | SCV005913514 | likely benign | Gardner syndrome; Turcot syndrome with polyposis | 2021-11-30 | criteria provided, single submitter | clinical testing |